Elevating Expectations: Vericiguat in Heart Failure with Reduced Ejection Fraction
Introduction: Heart failure (HF) with reduced ejection fraction (EF) poses high morbidity and mortality. Guidelines Directed Medical Therapy (GDMT) is essential, yet many patients experience significant symptoms. Vericiguat, a soluble guanylate cyclase stimulator, may serve as an adjunctive therapy...
Uloženo v:
| Hlavní autoři: | , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Wolters Kluwer Medknow Publications
2024-12-01
|
| Edice: | Journal of Pharmacy and Bioallied Sciences |
| Témata: | |
| On-line přístup: | https://journals.lww.com/10.4103/jpbs.jpbs_1392_24 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
